• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT 3.13% 3.3¢

SYNTARA LIMITED

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT 20/09/24 1 473
20/09/24 Last post  newB Comments Created with Sketch.  1  Views Created with Sketch.  473 
SNT
SNT - Media thread
20/09/24 9 3.2K
20/09/24 Last post  ma420 Comments Created with Sketch.  9  Views Created with Sketch.  3.2K 
SNT
where are those “newsflows”?
18/09/24 6 3.0K
18/09/24 Last post  newB Comments Created with Sketch.  6  Views Created with Sketch.  3.0K 
SNT
Syntara the science explained
2
17/09/24 81 29K
17/09/24 Last post  ma420 Comments Created with Sketch.  81  Views Created with Sketch.  29K 
SNT 03/09/24 7 2.8K
03/09/24 Last post  NZ Trader Comments Created with Sketch.  7  Views Created with Sketch.  2.8K 
SNT 30/08/24 0 224
30/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  224 
SNT 30/08/24 0 228
30/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  228 
SNT 30/08/24 14 5.2K
30/08/24 Last post  Milo617 Comments Created with Sketch.  14  Views Created with Sketch.  5.2K 

See All Discussions arrow Created with Sketch.

Timeline

Results of Meeting
20 Sep 11:07
 
Appendix 4G - Key to Corporate Governance Disclosures
30 Aug 14:57
 
Corporate Governance Statement 2024
30 Aug 14:55
 
Appendix 4E and Annual Report to shareholders
30 Aug 14:39
 
Notification of cessation of securities - SNT
21 Aug 14:39
 
Notice of General Meeting/Proxy Form
20 Aug 11:12
 
View More arrow Created with Sketch.
(20min delay)
Last
3.3¢
Change
0.001(3.13%)
Mkt cap ! $42.58M
Open High Low Value Volume
3.2¢ 3.3¢ 3.0¢ $46.02K 1.475M

Buyers (Bids)

No. Vol. Price($)
2 499656 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 210595 1
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
Last
3.2¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
3.1¢ 3.2¢ 3.0¢ 737360
Last updated 15.37pm 20/09/2024 ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.